Peer-Reviewed Scientific Publication Demonstrates Central Role of Neurotoxic Soluble Amyloid Oligomers in Driving Alzheimer’s Pathogenesis
editor In full transparency, the following was submitted to SOURCE media via its business wire service. *** FRAMINGHAM – Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of product…